Monthly Archives: July 2016

Ketamine Cousin Rapidly Lifts Depression Without Side Effects

GLYX-13, a molecular cousin to ketamine, induces similar antidepressant results without the street drug side effects, reported a preclinical study funded by the National Institute of Mental Health (NIMH) that was published last month inNeuropsychopharmacology. Background Major depression affects about … Continue reading →

Posted in News & updates | Leave a comment

Light Switches Brain Pathway On-and-Off to Dissect How Anxiety Works

Scientists, for the first time, have switched anxiety on-and-off in active animals by shining light at a brain pathway. Instinctively reclusive mice suddenly began exploring normally forbidding open spaces when a blue laser activated the pathway – and retreated into … Continue reading →

Posted in Anxiety | Leave a comment

Mood Disorders Predict Later Substance Abuse Problems

Mania symptoms and bipolar disorder II more likely to lead to substance abuse than depression January 9, 2008 • Science Update People with manic symptoms and bipolar disorder type II are at significant risk of later developing an alcohol abuse … Continue reading →

Posted in News & updates | Leave a comment

Continued Use of Stimulants for ADHD Likely Does Not Increase Risk for Hypertension, but May Affect Heart Rate

September 7, 2011 • Science Update Source: NIMH Chronic use of stimulant medication to treat attention deficit hyperactivity disorder (ADHD) in children does not appear to increase risk for high blood pressure over the long term, but it may have … Continue reading →

Posted in News & updates | Leave a comment

Prescribed stimulant use for ADHD continues to rise steadily

September 28, 2011 • Press Release NIH and AHRQ study finds pace of the rise has slowed in recent years Source: NIMH The prescribed use of stimulant medications to treat attention deficit hyperactivity disorder (ADHD) rose slowly but steadily from … Continue reading →

Posted in News & updates | Leave a comment